SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-159144
Filing Date
2022-05-25
Accepted
2022-05-25 08:32:02
Documents
15
Period of Report
2022-05-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d319158d8k.htm   iXBRL 8-K 29770
2 EX-1.1 d319158dex11.htm EX-1.1 140536
3 EX-5.1 d319158dex51.htm EX-5.1 11784
7 GRAPHIC g319158g0524202314951.jpg GRAPHIC 1843
  Complete submission text file 0001193125-22-159144.txt   353510

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA evlo-20220525.xsd EX-101.SCH 2848
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE evlo-20220525_lab.xml EX-101.LAB 17979
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE evlo-20220525_pre.xml EX-101.PRE 11253
9 EXTRACTED XBRL INSTANCE DOCUMENT d319158d8k_htm.xml XML 3345
Mailing Address 620 MEMORIAL DRIVE SUITE 500 CAMBRIDGE MA 02139
Business Address 620 MEMORIAL DRIVE SUITE 500 CAMBRIDGE MA 02139 781 479 2974
Evelo Biosciences, Inc. (Filer) CIK: 0001694665 (see all company filings)

IRS No.: 465594527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38473 | Film No.: 22958939
SIC: 2834 Pharmaceutical Preparations